Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene
about
Genetic determinants and potential therapeutic targets for pancreatic adenocarcinomaGenome-wide association study of pancreatic cancer in Japanese populationAnalysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer typesStructural basis for recruitment of BRCA2 by PALB2A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33Patient-derived tumour xenografts as models for oncology drug developmentInternational network of cancer genome projects.Targeted capture and massively parallel sequencing of 12 human exomesRecent progress in pancreatic cancerSusceptibility pathways in Fanconi's anemia and breast cancerReview of screening for pancreatic cancer in high risk individualsIdentifying druggable disease-modifying gene productsSurgical and molecular pathology of pancreatic neoplasmsClinical Genetic Testing in GastroenterologyMolecular therapeutics in pancreas cancerPancreatic Cancer GeneticsThe Landscape of Pancreatic Cancer Therapeutic Resistance MechanismsGenetics and biology of pancreatic ductal adenocarcinomaGenomic alterations in pancreatic cancer and their relevance to therapyPancreatic adenocarcinoma pathology: changing "landscape"Familial Pancreatic AdenocarcinomaEpidemiology and Inherited Predisposition for Sporadic Pancreatic AdenocarcinomaMolecular landscape of pancreatic cancer: implications for current clinical trialsInherited pancreatic cancer syndromesGenetic basis of pancreas cancer development and progression: insights from whole-exome and whole-genome sequencingEndoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancerSystemic therapies for pancreatic cancer--the role of pharmacogeneticsPancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parametersHuman correlates of provocative questions in pancreatic pathologySquamous cell carcinomas of the head and neck in Fanconi anemia: risk, prevention, therapy, and the need for guidelinesPersonalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer.The genetic heterogeneity of colorectal cancer predisposition - guidelines for gene discoveryHomologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteinsPALB2: the hub of a network of tumor suppressors involved in DNA damage responsesMitotic homologous recombination maintains genomic stability and suppresses tumorigenesisRAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombinationGermline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility geneCooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombinationGetting personalized cancer genome analysis into the clinic: the challenges in bioinformaticsLoss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppression
P2860
Q21129230-51EE24CB-E551-4718-9FAE-C5F46FDA8988Q21136247-A1CA4775-B0CB-4296-A963-C20E914C2A7FQ24170413-AE79A5E3-02FC-42D1-88DD-61C0A1BD7744Q24315745-C061A00F-F62D-4957-B983-2A487E512139Q24597370-32F1D538-20CF-451C-A198-AF92518B0EAFQ24604068-BF9239C4-522F-4B50-B272-6B0E123F4515Q24611474-D000A6EB-E80D-463C-9FA7-901C44959EBCQ24615381-A29C45D2-D666-4A28-A616-603D063C0819Q24626346-AB4E0747-6AEE-4977-B83C-59BFFDF14468Q24628760-C46C6841-DEC6-4967-9722-E7EB06C38EDBQ24630198-523E9F9C-B6DA-4D56-8745-4CED90A42797Q24646409-4F19CC04-06A5-4FB6-81F4-88D4F78B592FQ26748615-52CF74A7-7852-4B5E-B1D3-07488355FEC2Q26749157-FD3320F3-E8B9-4165-BE3B-86092B98BE07Q26751709-B8698254-770B-4A28-9023-FEF6E0020203Q26765235-FD3FA182-596D-47B5-BD90-7A87CE2BF99DQ26765247-F834E473-6B3A-438E-864B-E2870F18163FQ26765438-9A793F5B-981D-487E-BD57-B35148B12B11Q26781443-31B14C31-7C34-49DE-9477-464F7FB8BE52Q26799446-6A4A10C9-F71D-4DC9-9622-FA84A683D11FQ26801415-29CFBBFA-2086-4BEB-9E7A-35BB5F8EEF17Q26801418-A2486705-FF36-4C06-BB3C-948645674F7BQ26824528-9A8D2519-3885-4746-AB4E-DB2DC646EF5AQ26853530-1D932FD5-3124-4923-AC18-9366AEA5339CQ26991615-E42B6202-B82A-4335-9BA9-71996E83628AQ27010209-ABE6D98E-84B9-40ED-B6C6-A8E0EB40081EQ27021716-BAA50BD9-3214-47D0-88AB-84E75D946F08Q27022231-58837E69-D39E-405C-ACB2-D4F4140A278FQ27023576-895F16BB-ED93-40CC-8542-ECF537469E6BQ27686904-5ADA618F-75DD-4554-A73C-3419C3E1A39AQ27851614-BB249572-9CC6-43C3-A3B2-7DD98A737F5AQ28077234-B7D8837C-5AD9-42B5-AC45-BBF5A97766E6Q28085364-57A274BB-A940-4EE8-962D-7D8C41CD9BF8Q28243398-1485C4C6-BE49-406C-B7ED-8519554E1180Q28274000-97A7C84D-930F-4171-8024-413C5ED597C4Q28274789-C6BA6813-54CA-48DE-9A61-483A1C550224Q28280022-2A0428FC-C345-455D-842D-6EB0B9FD74C8Q28294199-CD2A1CDF-778F-481D-9710-7F1605309E00Q28394818-64940B36-1FD8-4119-A2E0-F20F9EBAA3AEQ28512158-42F7ACE9-74E7-4E64-9007-6C9815EF4325
P2860
Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene
@ast
Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene
@en
Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene
@nl
type
label
Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene
@ast
Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene
@en
Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene
@nl
prefLabel
Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene
@ast
Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene
@en
Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene
@en
P2093
Alison P Klein
Anirban Maitra
D Williams Parsons
Emily Palmisano
Giovanni Parmigiani
James R Eshleman
Jimmy Cheng-Ho Lin
Kieran Brune
Michael Borges
Mihoko Kamiyama
P2860
P3181
P356
10.1126/SCIENCE.1171202
P407
P50
P577
2009-04-10T00:00:00Z